NCT00107211View on ClinicalTrials.gov

Vaccine Therapy in Treating Patients Who Are Undergoing Surgery for Ductal Carcinoma In Situ of the Breast

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

January 31, 2005

Primary Completion Date

July 31, 2008

Study Completion Date

July 31, 2008

Conditions
Breast Cancer
Interventions
BIOLOGICAL

therapeutic autologous dendritic cells

PROCEDURE

conventional surgery

PROCEDURE

neoadjuvant therapy

Trial Locations (1)

19104-4283

Abramson Cancer Center of the University of Pennsylvania, Philadelphia

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Abramson Cancer Center at Penn Medicine

OTHER

NCT00107211 - Vaccine Therapy in Treating Patients Who Are Undergoing Surgery for Ductal Carcinoma In Situ of the Breast | Biotech Hunter | Biotech Hunter